{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T06:14:06Z","timestamp":1750227246650,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jmii.2024.04.001","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T21:50:06Z","timestamp":1712440206000},"page":"426-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan"],"prefix":"10.1016","volume":"57","author":[{"given":"Wei-Li","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Da","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0074-7721","authenticated-orcid":false,"given":"Hsin-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Min","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0772-869X","authenticated-orcid":false,"given":"Shang-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2024.04.001_bib1","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1200\/JCO.2008.16.8252","article-title":"AIDS-related malignancies: state of the art and therapeutic challenges","volume":"26","author":"Spano","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmii.2024.04.001_bib2","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/cid\/cit497","article-title":"Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort","volume":"57","author":"Hleyhel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2024.04.001_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jmii.2019.03.008","article-title":"Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan","volume":"53","author":"Liu","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2024.04.001_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djt158","article-title":"Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era","volume":"105","author":"Gopal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmii.2024.04.001_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajh.24251","article-title":"Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution","volume":"91","author":"Guillet","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmii.2024.04.001_bib6","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/cncr.26723","article-title":"Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma","volume":"118","author":"Barta","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jmii.2024.04.001_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clml.2018.01.004","article-title":"Safety and preliminary efficacy of vorinostat with R-EPOCH in high-risk HIV-associated non-Hodgkin\u2019s lymphoma (AMC-075)","volume":"18","author":"Ramos","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.jmii.2024.04.001_bib8","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2024.04.001_bib9","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/QAD.0000000000001652","article-title":"Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era","volume":"31","author":"Besson","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2024.04.001_bib10","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/bloodadvances.2021004458","article-title":"HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis","volume":"5","author":"Alderuccio","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jmii.2024.04.001_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/jnci\/djx249","article-title":"Differences in virological and immunological risk factors for non-Hodgkin and Hodgkin lymphoma","volume":"110","author":"Shepherd","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmii.2024.04.001_bib12","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2005-09-3600","article-title":"AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy","volume":"107","author":"Mounier","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2024.04.001_bib13","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2024.04.001_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1684-1182(10)60044-8","article-title":"Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan","volume":"43","author":"Yang","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2024.04.001_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jfma.2016.11.006","article-title":"Lymphoma in Taiwan: review of 1347 neoplasms from a single institution according to the 2016 revision of the world Health Organization classification","volume":"116","author":"Chuang","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2024.04.001_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00277-015-2513-x","article-title":"A nationwide population-based cross-sectional comparison of hematological malignancies incidences between Taiwan and the United States of America","volume":"95","author":"Wu","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmii.2024.04.001_bib17","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2024.04.001_bib18","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmii.2024.04.001_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2141.2007.06943.x","article-title":"Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial","volume":"140","author":"Ribera","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmii.2024.04.001_bib20","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1200\/JCO.2005.05.4684","article-title":"Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma","volume":"24","author":"Bou\u00e9","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmii.2024.04.001_bib21","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2024.04.001_bib22","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jmii.2024.04.001_bib23","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1200\/JCO.2003.03.036","article-title":"Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07","volume":"21","author":"Batchelor","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmii.2024.04.001_bib24","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1200\/JCO.2009.23.3239","article-title":"Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's lymphoma: United Kingdom National cancer Research Institute lymphoma group study ISRCTN 64141244","volume":"27","author":"Hoskin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmii.2024.04.001_bib25","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Available at: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv. C10\u2013C11."},{"key":"10.1016\/j.jmii.2024.04.001_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12185-019-02668-0","article-title":"The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese Society of Hematology Blood Disease Registry","volume":"110","author":"Hagiwara","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jmii.2024.04.001_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89316-y","article-title":"A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan","volume":"11","author":"Pei","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmii.2024.04.001_bib28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00277-015-2582-x","article-title":"Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection","volume":"95","author":"Ma","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmii.2024.04.001_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01057960","article-title":"Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients","volume":"20","author":"Bashir","year":"1994","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.jmii.2024.04.001_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.hoc.2005.05.004","article-title":"AIDS-related primary central nervous system lymphoma","volume":"19","author":"Kasamon","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jmii.2024.04.001_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2009.09.018","article-title":"Neurologic presentations of AIDS","volume":"28","author":"Singer","year":"2010","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jmii.2024.04.001_bib32","first-page":"199","article-title":"Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL)","volume":"9","author":"Raez","year":"1998","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.jmii.2024.04.001_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/neuonc\/now155","article-title":"Long-term survival in AIDS-related primary central nervous system lymphoma","volume":"19","author":"Gupta","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jmii.2024.04.001_bib34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1212\/WNL.0000000000004265","article-title":"Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy","volume":"89","author":"Moulignier","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jmii.2024.04.001_bib35","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","article-title":"Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients","volume":"122","author":"Barta","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2024.04.001_bib36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3324\/haematol.2017.180893","article-title":"Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study","volume":"103","author":"Schommers","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jmii.2024.04.001_bib37","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2009-08-231613","article-title":"Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma","volume":"115","author":"Sparano","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2024.04.001_bib38","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1097\/QAD.0b013e32832e531c","article-title":"Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group, Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy","volume":"23","author":"Bohlius","year":"2009","journal-title":"AIDS"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T11:50:04Z","timestamp":1717501804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118224000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1684118224000707"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2024.04.001","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2024.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}